MGNet: Investigating the Characteristics of Natural Killer Cells in Patients with Autoantibody-Mediated Autoimmune Diseases

24 apr 2024 · 1 min. 42 sec.

New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical...

mostra di più

New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases."

Read the paper here: https://journals.aai.org/jimmunol/article-abstract/212/5/785/266624/A-Noncanonical-CD56dimCD16dim-NK-Cell-Subset?redirectedFrom=fulltext

Learn more about MGNet: https://mgnet.rarediseasesnetwork.org

mostra meno